logo

For the Inventor, By the Inventor

Shanghai, China

Jing Xiong

This inventor holds 14 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignees: Novartis Ag, Hoffmann-La Roche Inc., Skyphy Networks Co., Ltd. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Xiong. Retrieved from https://idiyas.com/inventor/jing-xiong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 78.6

 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:

goldMedal7 out of 3,977 
 
Novartis Ag
 patents
silverMedal6 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents
bronzeMedal1 out of 1 
 
Skyphy Networks Co., Ltd
 patent
4. 1 out of 1 
 
Skyphy Networks Communication(shanghai)
 patent
where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 12655153 - Solid forms of a HBV core protein allosteric modifier (2026-06-16),
2. 12012421 - Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate (2024-06-18),
3. 12012420 - Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate (2024-06-18),
4. 11873302 - Solid forms of a compound of HBV core protein allosteric modifier (2024-01-16),
5. 11230559 - Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetate (2022-01-25),
6. 11142534 - Process for the preparation of 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds (2021-10-12),
7. 10507201 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors (2019-12-17),
8. 10463653 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors (2019-11-05),
9. 10130629 - Pharmaceutical combinations (2018-11-20),
10. 9896449 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors (2018-02-20),
11. 9802917 - Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide (2017-10-31),
12. 9533988 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors (2017-01-03),
13. 9266883 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors (2016-02-23),
14. 8792389 - Rapid deployment devices in wireless self-organizing networks and methods for same (2014-07-29),

Title: Inventor Jing Xiong - Revolutionizing Technology in Shanghai

Introduction: Jing Xiong is a pioneering inventor based in Shanghai, China, known for her groundbreaking contributions to the field of technology.

Latest Patents: Jing Xiong holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing her innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Jing Xiong has worked with top research institutions and leading tech companies to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout her career, Jing Xiong has collaborated with renowned scientists, engineers, and inventors from around the world, fostering a culture of innovation and knowledge sharing.

Conclusion: Jing Xiong's relentless pursuit of innovation and her passion for pushing the boundaries of technology make her a true trailblazer in the field of inventions, inspiring the next generation of inventors to dream big and create a better future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…